Literature DB >> 24692741

The role of prophylactic hyperthermic intraperitoneal chemotherapy in the management of serosal involved gastric cancer.

Edoardo Saladino1, Francesco Fleres, Carmelo Mazzeo, Vincenzo Pruiti, Michela Scollica, Maurizio Rossitto, Eugenio Cucinotta, Antonio Macrì.   

Abstract

BACKGROUND: Peritoneal carcinomatosis of gastric origin is associated with poor survival. The use of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) did not significantly improve the survival of patients with this disease. A promising approach can be based on the use of HIPEC as prophylaxis of peritoneal dissemination. PATIENTS AND METHODS: From our database, we have sampled 12 patients with advanced gastric cancer. In all cases, a D2 total gastrectomy was performed, associated with splenectomy in four cases. All patients were submitted to HIPEC.
RESULTS: Morbidity and mortality were 33.3% and 8.3%, respectively. The median survival was 24 months, with only one case (8.3%) of peritoneal recurrence.
CONCLUSION: In light of our experience and supported by literature data, we can affirm that HIPEC has a potential role in the prevention of gastric carcinomatosis. Certainly further studies are required on a larger scale to validate this new but promising approach.

Entities:  

Keywords:  Gastric cancer; HIPEC; prophylaxis

Mesh:

Year:  2014        PMID: 24692741

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  10 in total

1.  Prophylactic hyperthermic intraperitoneal chemotherapy can be considered in the management of advanced gastric cancer.

Authors:  Antonio Macrì; Edoardo Saladino
Journal:  J Gastrointest Oncol       Date:  2016-12

2.  Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) delivered via a modified perfusion system for peritoneal carcinomatosis of colorectal origin.

Authors:  Adrian Cravioto-Villanueva; Magdalena Cavazos; Pedro Luna-Perez; Hector Martinez-Gomez; María Lourdes Ramirez; Juan Solorzano; Hermelindo Montiel; Jesus Esquivel
Journal:  Surg Today       Date:  2016-04-30       Impact factor: 2.549

Review 3.  Multimodality treatment strategies have changed prognosis of peritoneal metastases.

Authors:  Corneliu Lungoci; Aurel Ion Mironiuc; Valentin Muntean; Traian Oniu; Hubert Leebmann; Max Mayr; Pompiliu Piso
Journal:  World J Gastrointest Oncol       Date:  2016-01-15

Review 4.  A narrative review of intraperitoneal chemotherapy and cytoreductive surgery (CRS) for peritoneal metastases in gastric cancer.

Authors:  Thomas Boerner; Pompiliu Piso
Journal:  J Gastrointest Oncol       Date:  2021-04

5.  Prognostic Factors and Recurrence Patterns in T4 Gastric Cancer Patients after Curative Resection.

Authors:  Bao-Yan Zhu; Shu-Qiang Yuan; Run-Cong Nie; Shu-Man Li; Li-Rong Yang; Jin-Ling Duan; Ying-Bo Chen; Xiao-Shi Zhang
Journal:  J Cancer       Date:  2019-01-29       Impact factor: 4.207

6.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal peritoneal metastases: analysis of short- and long-term outcomes.

Authors:  Fausto Rosa; Federica Galiandro; Riccardo Ricci; Dario Di Miceli; Giuseppe Quero; Claudio Fiorillo; Caterina Cina; Sergio Alfieri
Journal:  Langenbecks Arch Surg       Date:  2021-10-18       Impact factor: 3.445

Review 7.  Role of prophylactic HIPEC in non-metastatic, serosa-invasive gastric cancer: a literature review.

Authors:  Aditya R Kunte; Aamir M Parray; Manish S Bhandare; Sohan Lal Solanki
Journal:  Pleura Peritoneum       Date:  2022-07-04

Review 8.  [Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer].

Authors:  Felix Gronau; Maximilian Jara; Linda Feldbrügge; Vincent Wolf; Alan Oeff; Beate Rau
Journal:  Chirurg       Date:  2021-02-23       Impact factor: 0.955

9.  Wernicke encephalopathy as rare complication of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Authors:  Antonio Macrì; Francesco Fleres; Antonio Ieni; Maurizio Rossitto; Tommaso Mandolfino; Salvatore Micalizzi; Francesco Iaropoli; Carmelo Mazzeo; Massimo Trovato; Eugenio Cucinotta; Edoardo Saladino
Journal:  Int J Surg Case Rep       Date:  2015-09-18

Review 10.  Hyperthermic Intraperitoneal Chemotherapy in the Management of Gastric Cancer: A Narrative Review.

Authors:  Marek Mazurek; Małgorzata Szlendak; Alicja Forma; Jacek Baj; Ryszard Maciejewski; Giandomenico Roviello; Luigi Marano; Franco Roviello; Karol Polom; Robert Sitarz
Journal:  Int J Environ Res Public Health       Date:  2022-01-07       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.